SECTION 252:410-10-35. 10 CFR 35 incorporations by reference


Latest version.
  • (a)   Incorporations by reference. The following provisions are hereby incorporated by reference from 10 CFR 35, Medical Use of Byproduct Material:
    (1)   Subpart A; General Information.
    (A)   35.1 - Purpose and scope
    (B)   35.2 - Definitions
    (C)   35.5 - Maintenance of records
    (D)   35.6 - Provisions for the protection of human research subjects
    (E)   35.7 - FDA, other Federal and State requirements
    (F)   35.10 - Implementation
    (G)   35.11(a), (b) and (c)(2) - License required
    (H)   35.12 - Application for license, amendment or renewal
    (I)   35.13(a)(2), and (b) through (g) - License amendments
    (J)   35.14 - Notifications
    (K)   35.15 - Exemptions regarding Type A specific licenses of broad scope
    (L)   35.18 - License issuance
    (M)   35.19 - Specific exemptions
    (2)   Subpart B; General Administrative Requirements.
    (A)   35.24 - Authority and responsibilities for the radiation protection program
    (B)   35.26 - Radiation protection program changes
    (C)   35.27 - Supervision
    (D)   35.40 - Written directives
    (E)   35.41 - Procedures for administrations requiring a written directive
    (F)   35.49 - Suppliers for sealed sources or devices for medical use
    (G)   35.50 - Training for Radiation Safety Officer and Associate Radiation Safety Officer
    (H)   35.51 - Training for an authorized medical physicist
    (I)   35.55 - Training for an authorized nuclear pharmacist
    (J)   35.57 - Training for experienced Radiation Safety Officer, teletherapy or medical physicist, authorized user, nuclear pharmacist, and authorized nuclear pharmacist
    (K)   35.59 - Recentness of Training
    (3)   Subpart C; General Technical Requirements.
    (A)   35.60 - Possession, use, and calibration of instruments used to measure the activity of unsealed byproduct material
    (B)   35.61 - Calibration of survey instruments
    (C)   35.63 - Determination of dosages of unsealed byproduct material for medical use
    (D)   35.65 - Authorization for calibration, transmission, and reference sources
    (E)   35.67 - Requirements for possession of sealed sources and brachytherapy sources
    (F)   35.69 - Labeling of vials and syringes
    (G)   35.70 - Surveys of ambient radiation exposure rate
    (H)   35.75 - Release of individuals containing unsealed byproduct material or implants containing byproduct material
    (I)   35.80 - Provision of mobile medical service
    (J)   35.92 - Decay-in-storage
    (4)   Subpart D; Unsealed Byproduct Material-Written Directive Not Required.
    (A)   35.100 - Use of unsealed byproduct material for uptake, dilution, and excretion studies for which a written directive is not required
    (B)   35.190 - Training for uptake, dilution, and excretion studies
    (C)   35.200 - Use of unsealed byproduct material for imaging and localization studies for which a written directive is not required
    (D)   35.204 - Permissible molybdenum-99, strontium-82, and strontium-85 concentrations
    (E)   35.290 - Training for imaging and localization studies
    (5)   Subpart E; Unsealed Byproduct Material - Written Directive Required.
    (A)   35.300 - Use of unsealed byproduct material for which a written directive is required
    (B)   35.310 - Safety instruction
    (C)   35.315 - Safety precautions
    (D)   35.390 - Training for use of unsealed byproduct material for which a written directive is required
    (E)   35.392 - Training for the oral administration of sodium iodide I-131 requiring a written directive in quantities less than or equal to 1.22 gigabecquerels (33 millicuries)
    (F)   35.394 - Training for the oral administration of sodium iodide I-131 requiring a written directive in quantities greater than 1.22 gigabecquerels (33 millicuries)
    (G)   35.396 - Training for the parenteral administration of unsealed byproduct material requiring a written directive
    (6)   Subpart F; Manual Brachytherapy.
    (A)   35.400 - Use of sources for manual brachytherapy
    (B)   35.404 - Surveys after source implant and removal
    (C)   35.406 - Brachytherapy sources accountability
    (D)   35.410 - Safety instruction
    (E)   35.415 - Safety precautions
    (F)   35.432 - Calibration measurements of brachytherapy sources
    (G)   35.433 - Strontium-90 sources for ophthalmic treatments
    (H)   35.457 - Therapy related computer systems
    (I)   35.490 - Training for use of manual brachytherapy sources
    (J)   35.491 - Training for ophthalmic use of strontium-90
    (7)   Subpart G; Sealed Sources for diagnosis.
    (A)   35.500 - Use of sealed sources and medical devices for diagnosis
    (B)   35.590 - Training for use of sealed sources and medical devices for diagnosis
    (8)   Subpart H; Photon Emitting Remote Afterloader Units, Teletherapy Units, and Gamma Stereotactic Radiosurgery Units.
    (A)   35.600 - Use of a sealed source in a remote afterloader unit, teletherapy unit, or gamma stereotactic radiosurgery unit
    (B)   35.604 - Surveys of patients and human research subjects treated with a remote afterloader unit
    (C)   35.605 - Installation, maintenance, adjustment, and repair
    (D)   35.610 - Safety procedures and instructions for remote afterloader units, teletherapy units, and gamma stereotactic radiosurgery units
    (E)   35.615 - Safety precautions for remote afterloader units, teletherapy units, and gamma stereotactic radiosurgery units
    (F)   35.630 - Dosimetry equipment
    (G)   35.632 - full calibration measurements on teletherapy units
    (H)   35.633 - Full calibration measurements on remote afterloader units
    (I)   35.635 - Full calibration measurements on gamma sterotactic radiosurgery units
    (J)   35.642 - Periodic spot-checks for teletherapy units
    (K)   35.643 - Periodic spot-checks for remote afterloader units
    (L)   35.645 - Periodic spot-checks for gamma stereotactic radiosurgery units
    (M)   35.647 - Additional technical requirements for mobile remote afterloader units
    (N)   35.652 - Radiation surveys
    (O)   35.655 - Full-inspection servicing for teletherapy and gamma stereotactic radiosurgery units
    (P)   35.657 - Therapy-related computer systems
    (Q)   35.690 - Training for use of remote afterloader units, teletherapy units, and gamma stereotactic radiosurgery units
    (9)   Subpart I.
    (10)   Subpart K; Other Medical Uses of Byproduct Material or Radiation From Byproduct Material. 35.1000 - Other medical uses of byproduct material or radiation from byproduct material
    (11)   Subpart L; Records.
    (A)   35.2024 - Records of authority and responsibilities for radiation protection programs
    (B)   35.2026 - Records of radiation protection program changes
    (C)   35.2040 - Records of written directives
    (D)   35.2041 - Records for procedures for administration requiring a written directive
    (E)   35.2060 - Records of calibrations of instruments used to measure the activity of unsealed byproduct materials
    (F)   35.2061 - Records of radiation survey instrument calibrations
    (G)   35.2063 - Records of dosages of unsealed byproduct material for medical use
    (H)   35.2067 - Records of leaks tests and inventory of sealed sources and brachytherapy sources
    (I)   35.2070 - Records of survey for ambient radiation exposure rate
    (J)   35.2075 - Records of the release of individuals containing unsealed byproduct material or implants containing byproduct material
    (K)   35.2080 - Records of mobile medical services
    (L)   35.2092 - Records of decay-in-storage
    (M)   35.2204 - Records of molybdenum-99, strontium-82, and strontium 85 concentrations.
    (N)   35.2310 - Records of safety instruction
    (O)   35.2404 - Records of surveys after source implant and removal
    (P)   35.2406 - Records of brachytherapy source accountability
    (Q)   35.2432 - Records of calibration measurements of brachytherapy sources
    (R)   35.2433 - Records of decay of strontium-90 sources for ophthalmic treatments
    (S)   35.2605 - Records of installation, maintenance, adjustment, and repair of remote afterloader units, teletherapy units, and gamma stereotactic radiosurgery units
    (T)   35.2610 - Records of safety procedures
    (U)   35.2630 - Records of dosimetry equipment used with remote afterloader units, teletherapy units, and gamma stereotactic radiosurgery units
    (V)   35.2632 - Records of teletherapy, remote afterloader, and gamma stereotactic radiosurgery full calibrations
    (W)   35.2642 - Records of periodic spot-checks for teletherapy units
    (X)   35.2643 - Records of periodic spot-checks for remote afterloader units
    (Y)   35.2645 - Records of periodic spot checks for gamma sterotactic radiosurgery units
    (Z)   35.2647 - Records of additional technical requirements for mobile remote afterloader units
    (AA)   35.2652 - Records of surveys of therapeutic treatment units
    (BB)   35.2655 - Records of full-inspection servicing for teletherapy and gamma stereotactic radiosurgery units
    (12)   Subpart M; Reports.
    (A)   35.3045 - Report and notification of a medical event
    (B)   35.3047 - Report and notification of a dose to an embryo/fetus or a nursing child
    (C)   35.3067 - Report of a leaking source
    (D)   35.3204 - Report and notification for an eluate exceeding permissible molybdenum-99, strontium-82 and strontium-85 concentrations
    (b)   Exceptions. The provisions for communication with NRC of 10 CFR § 30.6 referenced in §§ 35.12 and 35.14 are not incorporated by reference. All correspondence regarding license requirements, and any notifications or reports required by this Part, shall be directed to DEQ.
[Source: Added at 17 Ok Reg 1136, eff 6-1-00; Amended at 21 Ok Reg 1539, eff 6-11-04; Amended at 22 Ok Reg 1458, eff 6-15-05; Amended at 24 Ok Reg 1290, eff 6-15-07; Amended at 26 Ok Reg 1193, eff 7-1-09; Amended at 29 Ok Reg 620, eff 7-1-12; Amended at 37 Ok Reg 1290, eff 9-15-20]